Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine

Keywords: health technology assessment, market access, National list of essential medicines

Abstract

Market access for pharmaceuticals is a set of strategies, activities and processes developed by pharmaceutical companies to provide affordable medicines at appropriate fair prices in a particular health care system. Access to the pharmaceutical market covers main areas of stages, including the health technology assessment (HTA).

The aim of the work was to analyze the stages of market access for pharmaceuticals in particular the implementation of HTA based on regulatory review, tasks and activities of the HTA Department of the State Expert Center of the Ministry of Health and the Expert Committee for Selection and Use of Essential Medicines and directions of HTA use in the health care system in Ukraine.

Materials: legislation governing the conduction of HTA in Ukraine, international publications on the subject of the study. Research methods: system and content analysis, data synthesis and generalization of information, extrapolation, retrospective analysis.

We have generalized the legislation for the introduction of HTA in Ukraine, the stages of institutionalization of the direction, the HTA roadmap, current state of financing of medicines using several regulatory lists from the perspective of state payer, including: National list of essential medicines, nomenclature of central procurement, insulin reimbursement. The mechanisms of selection of new medicines and evaluation with the use of HTA methods for inclusion on the regulatory lists, is in particular only for the National list, by criteria are presented: morbidity, disease prevalence and mortality; evidence of comparative efficacy (effectiveness), safety and cost-effectiveness; demand; the results of the budget impact analysis; pharmacokinetic properties of drugs; WHO recommendations on the use of essential medicines. In order to inform decisions on the rational allocation and use of financial resources in the health care system in January 2019, the HTA Department in Ukraine was established at SE "State Expert Center of the Ministry of Health of Ukraine" to conduct HTA and examination of applications for inclusion of medicines on National list.

It is substantiated that the institutionalization of the direction with the establishment of the HTA Department is an important step in ensuring the ecosystem of decision-making based on HTA in the Ukrainian health care system. The developed methodological support, in particular the first HTA guidelines, the model of multicriteria decision analysis, experience in assessment of applications for inclusion of medicines on the National list indicate the feasibility of further expanding the use of HTA for other regulatory lists, including the list of central procurement programs and development of single positive list of medicines for public funding in Ukraine.

References

1. Dixon T., Denny J., Nermeen A., Federico L., Hong Li. Chapter 17 – Market Access, Pharmaceutical Pricing, and Healthcare Costs, Editor(s): Dixon T. – Clinical Pharmacy Education, Practice and Research, Elsevier, 2019. – P. 249–259. https://doi.org/10.1016/B978-0-12-814276-9.00017-9
2. Toumi M. Introduction to market access for pharmaceuticals. – Boca Raton, FL : CRC Press, 2017. https://doi.org/10.1201/9781315314600
3. Market Access: From Being to Becoming. Pharmaceutical Executive. BCG Market Access Roundtable Working Group. – 2020. Accessed at: http://www.pharmexec.com/market-access-being-becoming
4. Pharmaceutical Innovation and Access to Medicines, OECD Health Policy Studies, OECD Publishing, Paris. – 2018. https://doi.org/10.1787/9789264307391-en
5. OECD (2020), Pharmaceutical spending (indicator). https://doi.org/10.1787/998febf6-en.
6. Development of the roadmap on access to medicines and vaccines 2019–2023: report by the Director-General. World Health Organization.Executive Board, 144. (2018). Accessed at: https://apps.who.int/iris/handle/10665/327421.
7. Zalis'ka O., Parnosky B. Farmacoekonomica: teoretuchni j practuchni naprjamu y sviti // Racionalnaja farmacoterapija. 2010. – № 4. – S. 7.
8. Piniazhko O., Zaliska O. Ilyk R. Pharmaceutical system in Ukraine: Implementation of external reference pricing, reimbursement programs and health technology assessment // Pharmacia. – 2018. – V. 65, N 2б. – P. 28–39.
9. Csanádi M., Inotai A., Oleshchuk O. et al. Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives // Inter. J. Technol. Assessment in Health Care. – 2019. – V. 35, N 5. – P. 393–400. https://doi.org/10.1017/S0266462319000679
10. Piniazhko O., Zaliska O. Metoduchni pidkhodu do provedennia ocinku tekhnologij okhronu zdorovja v Ukraini na osnovi evropejskoji modeli // Sotsialna farmatsiia v okhoroni zdorovia. – 2015. – Т. 1, № 2. – S. 44–54.
11. Mandrik O. Perspectuvu vucorustannia ocinku meduchnukh tekhnologij v Ukraini // Ukr. med. chasopus. – 2010. – № 6 (80) – S. 12–16.
12. Zalis’ka O., Piniazhko О., Maximovych N., Sichkoriz O., Tolubaiev V. Pharmaceutical system in Ukraine: current and prospective issues // J. Health Policy&Outcomes Res.– 2015.– N 2. – Р. 89–94.
13. Kosiachenko K. Metodologija ocinku tekhnologij okhronu zdorovja ta farmacii: aktualnist vprovadzennia v Ukraini // Upravlinnia, Ekonomika ta zabezpechennia jakosti v farmacii. – 2011. – № 1 (15) – S. 36–41.
14. Zalis'ka O., Mudrak I., Kolach T. Ocinka meduchnukh tekhnologij і farmacoekonomichnuj analiz pru vprovadzhenni formuliarnoji sustemu v Ukrajini // Farmats. zh. – 2010. – S. 15–18.
15. Nemchenko A., Kosiachenko K. Doslidzennia mizhnarodnogo dosvidu vprovadzhennia ocinku tekhnologij okhronu zdorovja // Farmats. zh. – 2011. – № 5. – S. 50–54.
16. Slabuj G. O., Marcov O. Ju., Horbenco O. V. Vid farmakoekonomichnukh doslidzen – do Ocinku meduchnukh tekhnologij: досвід країн світу // Ukraina. Zdorovji nacii. – 2011. – № 3 (19). – S. 132–142.
17. Tulubajev V. V. Zalis'ka O. Ocinka meduchnukh tekhnologij pru hronichnukh obstruktuvnukh zakhvorjuvanniakh lehen u populacii economichno actuvnogo naselennia Ukrainu // Farmats. chasopus – 2012. – № 3 (23) – S. 155–160.
18. Dumenko T. M. Analiz miznarodnoho dosvidu zastosuvannia ocinku tekhnologij v okhoroni zdorovja (Health Technology Assessment Place of publication // Visnuk socialnoji gigijenu ta organizacii okhoronu zdorovja Ukrajinu. – Ternopil, 2009. – № 3. – S. 76–82.
19. EUnetHTA Joint Action 2, Work Package 8. HTA Core Model version 3.0 (Базова модель Європейської мережі агенцій з оцінки медичних технологій 3.0) [Електронний ресурс]. – Режим доступу: www.htacoremodel.info
20. Inception Impact Assessment «Strengthening of the EU cooperation on Health Technology Assessment (HTA)» (Початкова оцінка впливу «Посилення співпраці ЄС з оцінки медичних технологій (HTA)) 2016. [Електронний ресурс]. – Режим доступу: http://ec.europa.eu/smart-regulation/roadmaps/docs/2016_sante_144_health_technology_assessments_en.pdf
21. Ducournau P. et al. Timely, consistent, transparent assessment of market access evidence: implementing tools based on the HTA Core Model® in a pharmaceutical company // Int. J. Technol. Assess Health Care. – 2019. – V. 35 (1). – P. 10–16. https://doi.org/10.1017/S0266462318003653
22. National Institute for Clinical Excellence (NICE). Guide to the processes of technology appraisal. London: National Institute for Clinical Excellence, 2018 (Рекомендації для процесу технологічної оцінки. Лондон: Національний інститут клінічної досконалості NICE, 2018) [Електронний ресурс]. – Режим доступу: https://www.nice.org.uk/process/pmg19/chapter/acknowledgements
23. Kirsanov D. Prohrama «Dostupni liky»: analiz onovlenoho reiestru vidshkoduvannia // Apteka.ua [Elektronnyi resurs]. – Rezhym dostupu: https://www.apteka.ua/article/465384
24. Postanova KMU No 333 vid 25. 03 .2019 r. Dejaki putannia derzhavnogo reguluvannia cin na likarski zasobu i vurobu meduchnogo pruznachennia. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/333-2009-п
25. Postanova KMU No 152 vid 17. 03. 2017 Pro zabezpechennia dostupnosti likarskukh zasobiv. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/152-2017-%D0%BF
26. Postanova KMU No 255 vid 13. 03. 2019 Pro zatverdzhennia pereliku likarskukh zasobiv ta meduchnukh vurobiv, jaki zacupovujutsia na pidstavi uhod shchodo zacupivli iz specializovanumu organizacijamu, jaki zdijsnjujut zacupivli za naprjamamu vukorustannia bjudzhetnukh koshtiv u 2019 roci za prohramoju “Zabezpechennia meduchnukh zakhodiv okremukh derzhavnukh program ta komplexnukh zakhodiv programnogo kharacteru”. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/255-2019-п
27. Postanova KMU No 73 vid 05. 03. 2014 Pro (iz zminamu) «Putannia realizaciji pilotnogo proektu shchodo zaprovadzhennia derzhavnogo reguluvannia cin na preparatu insulinu. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/73-2014-п
28. Zakon Ukrainu “Pro derzhavni finansovi garantii meduchnogo obslugovuvannia naselennia”. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/2168-19
29. Derzhavna strategija realizacii derzhavnoji polityky zabezpechennia naselennia likarskymy zasobamy na period do 2025 roky, zatverdzhena Postanovoju Cabinetu Ministriv Ukrainu 5grudnia 2018 r. № 1022. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/1022-2018-п
30. Nakaz MOZ Ukrainy vid 11. 02. 2016 № 84 «Polozhennia pro Nacionalnyj perelik osnovnukh likarskykh zasobiv». – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/z0258-16
31. Postanova KMU No 65 vid 05. 02. 2020 “Dejaki putannia realizacii programu derzhavnukh garantij meduchnogo obslugovuvannia naselennia u 2020 roci. – Rezhym dostupu: https://zakon.rada.gov.ua/laws/show/65-2020-%D0%BF
32. Korusni materialu. Oficijnuy sajt Expertnogo komitety z vidbory ta vukorustannia osnovnukh likarskukh zasobiv MOZ Ukrainu. – Rezhym dostupu: https://eml-ukraine.org.ua/korysni-materialy
33. Piniazhko O., Romanenko I., Leleka M. et al. Steps of the creation of a HTA-informed healthcare decision-making ecosystem in Ukraine. – Value In Health, 22. – P. 797. https://doi.org/10.1016/j.jval.2019.09.2114
34. Romanenko I., Serediuk V., Zakharian A. et al. Needs and risks assessment in creation of HTA-informed healthcare decision-making ecosystem in Ukraine. – Value In Health, 22. – P. 798–799. https://doi.org/10.1016/j.jval.2019.09.2122
35. Piniazhko O., Dumenko T., Malyshevska I. et al. SWOT analysis for creation of HTA ecosystem in Ukraine. – Value In Health, 22. – P. 796. https://doi.org/10.1016/j.jval.2019.09.2111
36. Dudlei M., Piniazhko O., Dumenko T. et al. Using PEST analysis to create an HTA-informed healthcare decision-making ecosystem in Ukraine. – Value In Health, 22. – P. 805. https://doi.org/10.1016/j.jval.2019.09.2155
37. Topachevskyi O., Piniazhko O., Romanenko I. et al. Disease prioritisation MCDA model for informing healthcare priorities setting іn Ukraine. – Value in Health, 22 – P. 256–257. May 2019.
38. 38. Oleshchuk O. M. Dumenko T. M. Piniazhko O. B. ta in. Recomendacii shchodo rozrobku shcalu rivniv vpluvu na bjudzhet pru ocinci zacupivli licarskukh zasobiv v Ukraini // Farmac. chasopus. – 2019. – № 3. – S. 92–101. https://doi.org/10.11603/2312-0967.2019.3.10402
39. Ukraine & HTA. EUnetHTA Magazine (Autumn 2019). – Rezhym dostupu: https://eunethta.foleon.com/eunethtamagazine/autumn-2019/partner-focus-ukraine-hta/
40. Assessments REA (2016–2021). EUnetHTA Assessment reports. – Rezhym dostupu: https://eunethta.eu/rapid-reas/
41. Kanavos P., Ferrario A., Tafuri G. Managing risk and uncertainty in health technology introduction: the role of managed entry agreements // Glob Policy. – 2017. – V. 8 (S2). – P. 84–92. – Rezhym dostupu: https://onlinelibrary.wiley.com/doi/full/10.1111/1758-5899.12386
Published
2020-07-09
How to Cite
Piniazhko, O. B., Kovtun, L. I., Zaliska, O. M., Oleshchuk, O. M., Leleka, M. V., & Topachevskyi, O. A. (2020). Implementation of health technology assessment at the stage of market access for pharmaceuticals in Ukraine. Farmatsevtychnyi Zhurnal, (3), 45-58. https://doi.org/10.32352/0367-3057.3.20.05
Section
Pharmacoeconomics